National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1) (PB 7 of 2016) (Cth)

PB 7 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1)

National Health Act 1953

I, DIANNA PROSSER, Assistant Secretary (Acting), Pharmaceutical Policy Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated      28       January 2016

DIANNA PROSSER

Assistant Secretary (Acting)

Pharmaceutical Policy Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1).

(2)   This Determination may also be cited as PB 7 of 2016.

1. Commencement

This Determination commences on 1 February 2016.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Apixaban

Omit

Apomorphine

[2]     Schedule 1, after item dealing with Rotigotine

Insert

Ruxolitinib

[3]     Schedule 1, after item dealing with Vitamins, minerals and trace elements with carbohydrate

Omit

Voriconazole

[4]     Schedule 2, after item dealing with Anastrozole

Insert

Apomorphine

[5]     Schedule 2, after item dealing with Vinorelbine

Insert

Voriconazole